Investors Snag NLTX 8.1% Cheaper Than Its Secondary Stock Offering

Looking back to 4 days ago, Neoleukin Therapeutics Inc (NLTX) priced a 3,262,471 share secondary stock offering at $15.25 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.